Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine fumarate plus remimazolam vs sufentanil plus propofol for painless gastroscopy in elderly patients
ChiCTR2600125370Phase 4Not yet recruiting
- Sponsor
- Quzhou People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine and remimazolam in procedural pain and anxiety disorder (2 arms), sponsored by Quzhou People's Hospital. Primary endpoints: Incidence of hypoxemia and Incidence of hypotension. Planned start May 2026; status: not yet recruiting.
02
Drugs
oliceridineremimazolam
03
Conditions
procedural painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2600125370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125370.